Porton Pharma Solutions Ltd. (300363.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 12.6B |
| Enterprise Value | 13.31B |
| P/E Ratio | -71.94 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 3.17 |
| Price/Book Ratio | 2.27 |
| Enterprise/Revenue | 3.38 |
| Enterprise/EBITDA | 58.25 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.04 |
| Operating Margin | -0.04 |
AD
Management Effectiveness
| Return On Assets | -0.02 |
| Return On Equity | -0.03 |
Income Statement
| Revenue | 3.4B |
| Revenue/Share | 6.68 |
| Gross Profit | 899.77M |
| EBITDA | 607.32M |
| Net Income | 96.34M |
| Diluted EPS | 0.18 |
Balance Sheet
| Total Cash | 1.27B |
| Total Cash/Share | 2.37 |
| Total Debt | 1.6B |
| Total Debt/Equity | 0.32 |
| Current Ratio | 2 |
| Book Value Per Share | 9.45 |
Price History
| 52-Week Change | -14.65 |
| 52-Week High | 30.4 |
| 52-Week Low | 13.24 |
| Moving Average 50 Days | 22.12 |
| Moving Average 200 Days | 20.42 |
Statistics
| Average Volume | 27.24M |
| Shares Outstanding | 543.44M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.09 |
| Trailing Annual Dividend Yield | 0.43 |
| Payout Ratio | -0.46 |
| Last Split Factor | 3:2 |
| Last Split Date | September 29, 2015 |
AD
